Takara Bio Stock

Takara Bio ROE 2024

Takara Bio ROE

0.01

Ticker

4974.T

ISIN

JP3460200003

WKN

A0DNGL

In 2024, Takara Bio's return on equity (ROE) was 0.01, a -93.59% increase from the 0.21 ROE in the previous year.

Takara Bio Aktienanalyse

What does Takara Bio do?

Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Takara Bio's Return on Equity (ROE)

Takara Bio's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Takara Bio's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Takara Bio's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Takara Bio’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Takara Bio stock

What is the ROE (Return on Equity) of Takara Bio this year?

The ROE of Takara Bio this year is 0.01 undefined.

How has the Return on Equity (ROE) of Takara Bio developed compared to the previous year?

The ROE of Takara Bio has increased by -93.59% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Takara Bio?

A high ROE indicates that Takara Bio generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Takara Bio?

A low ROE can indicate that Takara Bio is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Takara Bio affect the company?

A change in ROE (Return on Equity) of Takara Bio can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Takara Bio?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Takara Bio?

Some factors that can influence Takara Bio's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Takara Bio pay?

Over the past 12 months, Takara Bio paid a dividend of 17 JPY . This corresponds to a dividend yield of about 1.61 %. For the coming 12 months, Takara Bio is expected to pay a dividend of 19.79 JPY.

What is the dividend yield of Takara Bio?

The current dividend yield of Takara Bio is 1.61 %.

When does Takara Bio pay dividends?

Takara Bio pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Takara Bio?

Takara Bio paid dividends every year for the past 16 years.

What is the dividend of Takara Bio?

For the upcoming 12 months, dividends amounting to 19.79 JPY are expected. This corresponds to a dividend yield of 1.87 %.

In which sector is Takara Bio located?

Takara Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Takara Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Takara Bio from 6/1/2024 amounting to 17 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Takara Bio pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Takara Bio in the year 2023?

In the year 2023, Takara Bio distributed 42 JPY as dividends.

In which currency does Takara Bio pay out the dividend?

The dividends of Takara Bio are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Takara Bio

Our stock analysis for Takara Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Takara Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.